Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2015 |
| Author/s |
author: Kathleen M Schmainda |
| Publication date | September 11, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |